Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2017-2027

Global Vaccine Contract Manufacturing Market Report 2017-2027

Leading Countries, Technologies and Companies

PUBLISHED: 23 February 2017
PAGES: 154
PRODUCT CODE: PHA0172

Clear
WOOCS 2.2.1
SKU: PHA0172 Categories: , ,

The global vaccine contract manufacturing market is expected to grow at a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. The market is expected to grow at a CAGR of 9.1% from 2016 to 2027. The market is estimated at $816m in 2016, and $2117m in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 74 charts – all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Vaccine Contract Manufacturing Market Report 2017-2027

Report Scope
• Revenue and growth forecasts to 2027 for the global vaccine market and market shares of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2027 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2027 for the leading national markets:
– United States
– Germany
– France
– United Kingdom
– Italy
– Spain
– Japan
– Brazil
– Russia
– China
– India
– Rest of the World

• Revenue and growth forecasts to 2027 for the leading players in the vaccine contract manufacturing market:
– Baxter BioPharma Solutions
– Boehringer Ingelheim
– Catalent
– Charles River Laboratories
– IDT Biologika
– Lonza
– Meridian Life Science
– Sigma Aldrich Fine Chemicals
– Merck
– Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2017-2027: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories